Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated:  11/30/2015
Clinical Research Facility
1778
mi
from 43215
Spokane, WA
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Clinical Research Facility
1778
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated:  11/30/2015
Clinical Research Facility
164
mi
from 43215
Morgantown, WV
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Clinical Research Facility
164
mi
from 43215
Morgantown, WV
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated:  11/30/2015
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated:  11/30/2015
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated:  11/30/2015
Clinical Research Facility
403
mi
from 43215
Neenah, WI
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Clinical Research Facility
403
mi
from 43215
Neenah, WI
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated:  11/30/2015
Clinical Research Facility
961
mi
from 43215
Coconut Creek, FL
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Clinical Research Facility
961
mi
from 43215
Coconut Creek, FL
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated:  11/30/2015
Clinical Research Facility
966
mi
from 43215
Sunrise, FL
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Clinical Research Facility
966
mi
from 43215
Sunrise, FL
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated:  11/30/2015
4525
mi
from 43215
Linz,
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
4525
mi
from 43215
Linz,
Click here to add this to my saved trials
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Status: Enrolling
Updated:  11/30/2015
Kessler Rehabillitation Institute
463
mi
from 43215
West Orange, NJ
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Status: Enrolling
Updated: 11/30/2015
Kessler Rehabillitation Institute
463
mi
from 43215
West Orange, NJ
Click here to add this to my saved trials
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Status: Enrolling
Updated:  11/30/2015
University of Missouri-Kansas City
618
mi
from 43215
Kansas City, MO
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Status: Enrolling
Updated: 11/30/2015
University of Missouri-Kansas City
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Status: Enrolling
Updated:  11/30/2015
Kessler Rehabilitation Institute
465
mi
from 43215
West Orange, NJ
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Status: Enrolling
Updated: 11/30/2015
Kessler Rehabilitation Institute
465
mi
from 43215
West Orange, NJ
Click here to add this to my saved trials
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Status: Enrolling
Updated:  11/30/2015
University of Missouri-Kansas City
618
mi
from 43215
Kansas City, MO
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Status: Enrolling
Updated: 11/30/2015
University of Missouri-Kansas City
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Advanced MRI Applications for Mild Traumatic Brain Injury
Advanced MRI Applications for Mild Traumatic Brain Injury
Status: Enrolling
Updated:  11/30/2015
Hospital for Special Surgery
480
mi
from 43215
New York, NY
Advanced MRI Applications for Mild Traumatic Brain Injury
Advanced MRI Applications for Mild Traumatic Brain Injury
Status: Enrolling
Updated: 11/30/2015
Hospital for Special Surgery
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
Status: Enrolling
Updated:  11/30/2015
University of California at San Francisco (UCSF)
2109
mi
from 43215
San Francisco, CA
Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
Status: Enrolling
Updated: 11/30/2015
University of California at San Francisco (UCSF)
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated:  11/30/2015
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated:  11/30/2015
UCSD Movement Disorder Clinic
1957
mi
from 43215
La Jolla, CA
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
UCSD Movement Disorder Clinic
1957
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated:  11/30/2015
UCSF Neurosciences Clinical Research Unit
1982
mi
from 43215
San Francisco, CA
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
UCSF Neurosciences Clinical Research Unit
1982
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated:  11/30/2015
Molecular Neuroimaging, LLC
537
mi
from 43215
New Haven, CT
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Molecular Neuroimaging, LLC
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated:  11/30/2015
Perelman School of Medicine
416
mi
from 43215
Philadelphia, PA
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Perelman School of Medicine
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
TBI MR Study 3 Houston Methodist
Advanced MRI Applications for Mild Traumatic Brain Injury - Study 3
Status: Enrolling
Updated:  11/30/2015
Houston Methodist Neurological Institute
995
mi
from 43215
Houston, TX
TBI MR Study 3 Houston Methodist
Advanced MRI Applications for Mild Traumatic Brain Injury - Study 3
Status: Enrolling
Updated: 11/30/2015
Houston Methodist Neurological Institute
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial
Status: Enrolling
Updated:  11/30/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial
Status: Enrolling
Updated: 11/30/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
Improving Affect and Behavior in Assisted Living Residents
Status: Enrolling
Updated:  11/30/2015
University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
Improving Affect and Behavior in Assisted Living Residents
Status: Enrolling
Updated: 11/30/2015
University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
Improving Affect and Behavior in Assisted Living Residents
Status: Enrolling
Updated:  11/30/2015
Rush University School of Nursing
277
mi
from 43215
Chicago, IL
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
Improving Affect and Behavior in Assisted Living Residents
Status: Enrolling
Updated: 11/30/2015
Rush University School of Nursing
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Facilitating Caregiver Adaptation to Patient Institutionalization
Intervention to Facilitate Family Caregiver Adaptation to Nursing Home Transition
Status: Enrolling
Updated:  11/30/2015
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Facilitating Caregiver Adaptation to Patient Institutionalization
Intervention to Facilitate Family Caregiver Adaptation to Nursing Home Transition
Status: Enrolling
Updated: 11/30/2015
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Psychological Effects of Tai Chi Training
Psychological Effects of Tai Chi Training
Status: Enrolling
Updated:  12/1/2015
University of Wisconsin-Madison, Waisman Center
392
mi
from 43215
Madison, WI
Psychological Effects of Tai Chi Training
Psychological Effects of Tai Chi Training
Status: Enrolling
Updated: 12/1/2015
University of Wisconsin-Madison, Waisman Center
392
mi
from 43215
Madison, WI
Click here to add this to my saved trials
A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
A Double-Blind, Repeat-Dose, Parallel Group Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness.
Status: Enrolling
Updated:  12/1/2015
Jean Brown Research
1512
mi
from 43215
Salt Lake City, UT
A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
A Double-Blind, Repeat-Dose, Parallel Group Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness.
Status: Enrolling
Updated: 12/1/2015
Jean Brown Research
1512
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
ARC in Hemorrhagic Stroke
Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit
Status: Enrolling
Updated:  12/1/2015
University of North Carolina Hospitals
344
mi
from 43215
Chapel Hill, NC
ARC in Hemorrhagic Stroke
Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit
Status: Enrolling
Updated: 12/1/2015
University of North Carolina Hospitals
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
Project GET FIT With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
Status: Enrolling
Updated:  12/1/2015
University of Illinois at Urbana-Champaign
mi
from 43215
Urbana-Champaign, IL
Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
Project GET FIT With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
Status: Enrolling
Updated: 12/1/2015
University of Illinois at Urbana-Champaign
mi
from 43215
Urbana-Champaign, IL
Click here to add this to my saved trials
Intra-arterial Magnesium Administration for Acute Stroke
Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
Status: Enrolling
Updated:  12/2/2015
University California Los Angeles: Ronald Reagan and Santa Monica Hospitals
1972
mi
from 43215
Los Angeles, CA
Intra-arterial Magnesium Administration for Acute Stroke
Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
Status: Enrolling
Updated: 12/2/2015
University California Los Angeles: Ronald Reagan and Santa Monica Hospitals
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Intra-arterial Magnesium Administration for Acute Stroke
Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
Status: Enrolling
Updated:  12/2/2015
University of Southern California University and LA County Hospitals
1972
mi
from 43215
Los Angeles, CA
Intra-arterial Magnesium Administration for Acute Stroke
Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
Status: Enrolling
Updated: 12/2/2015
University of Southern California University and LA County Hospitals
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Study of Pregnenolone in the Treatment of Individuals With Autism
An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism
Status: Enrolling
Updated:  12/2/2015
Stanford University School of Medicine
2100
mi
from 43215
Stanford, CA
A Study of Pregnenolone in the Treatment of Individuals With Autism
An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism
Status: Enrolling
Updated: 12/2/2015
Stanford University School of Medicine
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
An Open-Label Study of N-Acetyl Cysteine in Children With Autism
An Open-Label Study of N-Acetyl Cysteine in Autism
Status: Enrolling
Updated:  12/2/2015
Stanford University School of Medicine
2100
mi
from 43215
Stanford, CA
An Open-Label Study of N-Acetyl Cysteine in Children With Autism
An Open-Label Study of N-Acetyl Cysteine in Autism
Status: Enrolling
Updated: 12/2/2015
Stanford University School of Medicine
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
Multiphase Study to Determine if Platelet Function Analysis Results Correlate With Ischemic Events and Bleeding Complications
Status: Enrolling
Updated:  12/2/2015
Northwestern University
274
mi
from 43215
Chicago, IL
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
Multiphase Study to Determine if Platelet Function Analysis Results Correlate With Ischemic Events and Bleeding Complications
Status: Enrolling
Updated: 12/2/2015
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Status: Enrolling
Updated:  12/3/2015
Beth Israel Deaconess Medical Center
643
mi
from 43215
Boston, MA
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Status: Enrolling
Updated: 12/3/2015
Beth Israel Deaconess Medical Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  12/3/2015
Kellogg Eye Center
167
mi
from 43215
Ann Arbor, MI
In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 12/3/2015
Kellogg Eye Center
167
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
Status: Enrolling
Updated:  12/3/2015
Georgetown University
328
mi
from 43215
Washington,
Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
Status: Enrolling
Updated: 12/3/2015
Georgetown University
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
Status: Enrolling
Updated:  12/3/2015
MedStar National Rehabilitation Hospital
328
mi
from 43215
Washington,
Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
Status: Enrolling
Updated: 12/3/2015
MedStar National Rehabilitation Hospital
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
Status: Enrolling
Updated:  12/3/2015
Emory University
435
mi
from 43215
Atlanta, GA
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
Status: Enrolling
Updated: 12/3/2015
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
Status: Enrolling
Updated:  12/3/2015
Washington University, St. Louis
398
mi
from 43215
St. Louis, MO
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
Status: Enrolling
Updated: 12/3/2015
Washington University, St. Louis
398
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis
Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis
Status: Enrolling
Updated:  12/4/2015
University of Rochester
354
mi
from 43215
Rochester, NY
Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis
Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis
Status: Enrolling
Updated: 12/4/2015
University of Rochester
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
Status: Enrolling
Updated:  12/4/2015
San Francisco VA Medical Center
2111
mi
from 43215
San Francisco, CA
Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
Status: Enrolling
Updated: 12/4/2015
San Francisco VA Medical Center
2111
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke
Real vs Sham rTMS Combined With Conventional Therapy in Acute Stroke
Status: Enrolling
Updated:  12/4/2015
Courage Kenny Rehabilitation Institute
623
mi
from 43215
Minneapolis, MN
Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke
Real vs Sham rTMS Combined With Conventional Therapy in Acute Stroke
Status: Enrolling
Updated: 12/4/2015
Courage Kenny Rehabilitation Institute
623
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated:  12/4/2015
Information on additional locations involved in this clinical trial contact Chelsea Therapeutics
360
mi
from 43215
Charlotte, NC
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
Information on additional locations involved in this clinical trial contact Chelsea Therapeutics
360
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated:  12/4/2015
Wisconsin Institute for Neurology and Sleep Disorders
329
mi
from 43215
Milwaukee, WI
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
Wisconsin Institute for Neurology and Sleep Disorders
329
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated:  12/4/2015
NYU Langone Medical Center
478
mi
from 43215
New York, NY
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
NYU Langone Medical Center
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Status: Enrolling
Updated:  12/4/2015
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Status: Enrolling
Updated: 12/4/2015
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Status: Enrolling
Updated:  12/4/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 43215
Halifax,
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Status: Enrolling
Updated: 12/4/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 43215
Halifax,
Click here to add this to my saved trials
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated:  12/7/2015
University of California, Los Angeles Stroke Network
1982
mi
from 43215
Los Angeles, CA
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated: 12/7/2015
University of California, Los Angeles Stroke Network
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated:  12/7/2015
Jackson Memorial Hospital
992
mi
from 43215
Miami, FL
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated: 12/7/2015
Jackson Memorial Hospital
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated:  12/7/2015
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated: 12/7/2015
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials